Table 2.
Data after the index ablation and from the 3-month electrophysiology procedure.
| Total (n = 41) |
ERAF (n = 17) |
No ERAF (n = 24) |
Univariate p | |
|---|---|---|---|---|
| AADs at discharge after the index CA | ||||
| Propafenone | 21 (51.2%) | 9 (52.9%) | 12 (50.0%) | 0.853 |
| Amiodarone | 8 (19.5%) | 4 (23.5%) | 4 (16.7%) | 0.586 |
| Sotalol | 8 (19.5%) | 3 (17.6%) | 5 (20.8%) | 0.800 |
| Beta-blockers | 3 (7.3%) | 0 (0%) | 3 (12.5%) | 0.999 |
| Verapamil | 1 (2.4%) | 1 (5.9%) | 0 (0%) | >0.999 |
| Inflammatory markers after the index CA | ||||
| Leukocytes (n, 109/l) | 9.0 (7.4–10.7) |
8.0 (6.9–10.8) |
9.0 (8.0–10.5) |
0.843 |
| Neutrophiles (n, 109/l) | 6.0 (5.0–8.0) | 6.0 (4.9–7.8) | 6.0 (5.3–8.5) | 0.886 |
| ESR (mm/h) | 12.0 (8.0–22.0) |
10.0 (6.0–16.0) |
13.0 (10.0–26.0) |
0.074 |
| Fibrinogen (g/l) | 3.5 ± 0.9 | 3.3 ± 1.0 | 3.7 ± 0.9 | 0.249 |
| CRP (mg/l) | 12.1 (7.4–19.0) |
12.6 (8.0–22.0) |
11.5 (6.6–16.0) |
0.222 |
| Troponin I (ng/l) | 6.0 (5.0–9.0) | 5.0 (3.6–9.5) | 6.5 (6.0–9.0) | 0.719 |
| CK-MB (u/l) | 19.0 (16.5–23.5) |
19.0 (15.0–22.0) |
21.0 (18.0–25.0) |
0.287 |
| 3-month Follow-up EP procedure | ||||
| PV reconnection | 25 (61.0%) | 15 (88.2%) | 10 (41.7%) | 0.006 |
| Left PVs reconnection | 15 (36.6%) | 8 (47.1%) | 7 (29.2%) | 0.245 |
| Right PVs reconnection | 21 (51.2%) | 14 (82.4%) | 7 (29.2%) | 0.002 |
| PVs with late reconnection (n) | 1.0 (0.0–2.0) | 2.0 (1.0–4.0) | 0.0 (0.0–2.0) | 0.007 |
| Left PVI segments with reconnection (n) | 0.0 (0.0–1.0) | 0.0 (0.0–1.0) | 0.0 (0.0–1.0) | 0.170 |
| Right PVI segments with reconnection (n) | 1.0 (0.0–1.0) | 1.0 (1.0–2.0) | 0.0 (0.0–1.0) | 0.002 |
| Gap in the Roof line | 13 (31.7%) | 9 (52.9%) | 4 (16.7%) | 0.018 |
| Gap in the Mitral isthmus line | 15 (36.6%) | 6 (35.3%) | 9 (37.5%) | 0.885 |
Data are presented as mean ± standard deviation, median (25th to 75th percentile) or numbers (percentages).
ERAF, early recurrence of atrial fibrillation; AAD, anti-arrhythmic drug; CA, catheter-ablation; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; CK-MB, creatin-kinase MB iso-enzyme; EP, electrophysiology; PV, pulmonary vein; PVI, pulmonary vein isolation.